Biologics Use in Asian Indian Patients with Ankylosing Spondylitis: A Physician’s Perspective

Biologics Use in Asian Indian Patients with Ankylosing Spondylitis: A Physician’s Perspective

Introduction: Ankylosing Spondylitis (AS) with non-steroidal anti-inflammatory drug (NSAID) therapeutic failure is treated with biologics. Aim: To compare the clinical outcomes of different biologics for Asian Indian patients with AS who have NSAID therapeutic failure. Materials and Methods: Th...

Full description

Bibliographic Details
Main Authors:	Anuj Singhal, Darshan Bhakuni, Vishal Marwaha, Vivek Hande, Garvit Bagga
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2016-07-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	disease activity etanercept infliximab spondyloarthritis
Online Access:	https://jcdr.net/articles/PDF/8172/19960_CE(RA1)_F(T)_PF1(ROAK)_PFA(AK)_PF2(PAG).pdf

Similar Items

CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2018-05-01)

A Review on the Effect of Tumor Necrosis Factor Inhibitors on Structural Progression in Early Axial Spondyloarthritis Using Magnetic Resonance Imaging
by: Ko-Jen Li, et al.
Published: (2019-02-01)

Analysis and evaluation of the cost of the treatment anti-TNFα in rheumatoid arthritis and ankylosing spondylitis. Individualised front marketed dose
by: Félix Gómez-De Rueda, et al.
Published: (2017-06-01)

Comparative Efficacy and Acceptability of Anti-TNF-Alpha Therapy in Ankylosing Spondylitis: A Mixed-Treatments Comparison
by: Yehua Wang, et al.
Published: (2016-09-01)

Experience of etanercept treatment in juvenile ankylosing spondyloarthritis
by: A. N. Fetisova, et al.
Published: (2013-03-01)

Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry
by: Proton Rahman, et al.
Published: (2020-11-01)

Tratamiento biológico en psoriasis: Revisión bibliográfica Biologic therapy of psoriasis: Literature review
by: MS Lorenzetti, et al.
Published: (2012-06-01)

Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01)

Effective use of TNF antagonists
by: Yocum, David
Published: (2004)

Clinical experience with two etanercept biosimilars in Indian patients with spondyloarthritis
by: Ashok Kumar, et al.
Published: (2017-01-01)

Uveitis in Patients with Ankylosing Spondylitis
by: Anjal Bisht, et al.
Published: (2021-04-01)

Evaluation of the cost saving potential of introducing Benepali® and Flixabi® on the European and Italian markets
by: Cristina Negrini, et al.
Published: (2017-10-01)

Incidencia de tuberculosis en pacientes con psoriasis que reciben terapias anti- TNF- alfa en Latinoamérica: revisión sistemática y metaanálisis
by: Roniel Gonzalo Contreras Maza
Published: (2019-03-01)

New Treatment Alternatives in the Management of Non-‹nfectious ‹ntraocular ‹nflammations: Biologic Agents
by: Sinan Emre, et al.
Published: (2011-08-01)

Ankylosing spondylitis and non-radiographic axial spondyloarthritis: Two stages of disease?
by: D G Rumyantseva, et al.
Published: (2017-05-01)

A single center experience: physician related diagnostic delay and demographic and clinical differences between patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis
by: Ulutaş Firdevs, et al.
Published: (2021-09-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
by: Viola Sacchi, et al.
Published: (2010-06-01)

Cost-effectiveness study of treatment with biologic disease-modifying antirheumatic drugs in adult patients with active ankylosing spondylitis
by: R. O. Dreval
Published: (2021-02-01)

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01)

The effect of infliximab on depressive symptoms in patients with ankylosing spondylitis
by: Emine Duygu Ersözlü-Bozkırlı, et al.
Published: (2015-07-01)

Redução das imunoglobulinas induzida pelo abatacepte não se associa com eventos infecciosos
by: Valquiria Garcia Dinis
Published: (2017)

Redução das imunoglobulinas induzida pelo abatacepte não se associa com eventos infecciosos
by: Dinis, Valquiria Garcia
Published: (2017)

Equivalence and switching between biosimilars and reference molecules in rheumatoid arthritis: protocol for a systematic review and meta-analysis
by: Bruna O. Ascef, et al.
Published: (2021-07-01)

Evaluation of Therapeutic Drug Monitoring in the Clinical Management of Patients with Rheumatic Diseases: Data from a Retrospective Single-Center Cohort Study
by: Pedersen L, et al.
Published: (2020-10-01)

UTILIZAÇÃO OFF-LABEL DE TERAPÊUTICA BIOLÓGICA EM DERMATOLOGIA – EXPERIÊNCIA CLÍNICA DE 5 ANOS
by: Filipa Diamantino, et al.
Published: (2016-11-01)

LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH AUTOIMMUNE DISEASES TREATED WITH INFLIXIMAB AND ETANERCEPT
by: Luis Gabriel Parra-Lara
Published: (2019-04-01)

Targeting psoriasis with new therapies
by: A.Prohić;H. Helppikangas;J. Muhović
Published: (2007-08-01)

Complicações Imediatas de 3.555 aplicações de agentes anti-TNFα Immediate complications of 3,555 injections of anti-TNFα
by: Júlio César Bertacini de Moraes, et al.
Published: (2010-04-01)

THE NEED AND POSSIBILITIES OF EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS: COMMENTARIES ON THE PAPER «EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS» (No. 4, 2013) AND DISCUSSION IN THE JOURNAL (No. 2, 2014)
by: Sh. F. Erdes
Published: (2014-09-01)

Systemic Psoriasis Treatment at an Early Age (Part II): Issues of Biological Therapy
by: L. S. Namazova-Baranova, et al.
Published: (2018-02-01)

Uso do infliximabe e aparecimento sequencial de autoanticorpos e neoplasia em paciente com espondiloartrite Infliximab use and sequential occurrence of autoantibodies and neoplasia in a patient with spondyloarthritis
by: Ricardo Golmia, et al.
Published: (2010-12-01)

Experience with long-term infliximab therapy in patients with ankylosing spondylitis
by: Oksana Alekseevna Rumyantseva, et al.
Published: (2010-12-01)

The efficacy and safety of infliximab in patients with ankylosing spondylitis: results of an open-labeled multicenter study
by: Nikolay Vasil'evich Bunchuk, et al.
Published: (2010-10-01)

Acute fulminant drug induced necrotizing pancreatitis in a patient with ankylosing spondylitis
by: Pablo Miramontes, et al.
Published: (2015-03-01)

HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE
by: A. S. Kolbin, et al.
Published: (2016-12-01)

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany
by: Evelien Moorkens, et al.
Published: (2020-10-01)

Ankylosing spondylitis morbidity trends in Russia and Saturday spondyloarthritis schools
by: Shandor Fedorovich Erdes, et al.
Published: (2013-04-01)

Symptom modifiers in therapy for ankylosing spondylitis
by: V. V. Badokin
Published: (2010-06-01)

Ankylosing Spondylitis: A Review
by: Farrouq Mahmood, et al.
Published: (2017-11-01)

The clinical management of patients with ankylosing spondylitis in a real-world cohort
by: Patel, Akash R.
Published: (2020)